about
Cryptochromes mediate rhythmic repression of the glucocorticoid receptorInhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cellsSMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasisFibroblast Growth Factor Signaling in Metabolic RegulationHepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in miceEndocrinization of FGF1 produces a neomorphic and potent insulin sensitizerRecent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolismPolymorphisms affecting function of the human organic cation transporter hOCT1 (SLC22A1)Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice.ERRgamma regulates cardiac, gastric, and renal potassium homeostasis.The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation.Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk.A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis.Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cationsFXR and PXR: potential therapeutic targets in cholestasis.Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver diseaseEvidence for orphan nuclear receptor TR4 in the etiology of Cushing diseaseHepatobiliary ABC transporters: physiology, regulation and implications for disease.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo.Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction.Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP/ABCG2).The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine.The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ.Renal organic cation and nucleoside transport.Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart.Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX
P50
Q24299891-F14B7523-A718-48F5-BB6B-2FE9191E9646Q24318126-9560F2B0-6412-4C7D-BDC3-B9EC34481FCCQ24647529-C37A0434-8CD8-4C67-AA09-6E0DE1BB0C5FQ26772751-8A150AD7-C2A0-4F4E-B7A3-0296792151E1Q27320737-3FCAF0E4-34E0-4DC0-9489-63C45A366ECDQ28244332-64B621C9-BC98-41DA-8249-768483FD3CF7Q28569123-7CF9AF3E-A880-420C-BBF2-8DB0FA44E03AQ29037221-5A2C5778-E3C7-498C-BB99-19125CD4F940Q33218417-9936968D-2E2F-41B3-83FD-6A2FD3D9F563Q33634214-616EAE09-0FC3-4419-8CB6-4FF645C63DBAQ34388548-DACE165E-9424-44D0-83EE-172C7527806AQ34463631-DA245B71-E5C7-4E7B-A223-75F516D8BEC5Q35048738-376B00AF-7E20-404A-9E44-079227D09EF9Q35566946-F5A95DED-B63E-4F3E-BCD0-1FC9D1441F05Q35641888-DD2EEF03-2173-4A7B-BC4A-CE97F803AFF0Q35981284-D5A4E6F3-1891-4E1E-93A0-22BA1F6EC5BEQ36139458-4B6F7ABD-AFFD-4F58-9F1A-33AD0F92A778Q36572561-9CF8E9A8-8FCB-431E-86A7-E785C9DA67A0Q36646646-85B111CF-F186-45BF-9DDE-F44F052A6631Q36884281-46005A2F-117D-44CD-BF52-0B3BEA21D875Q37501757-BFEF7CF7-2DE8-4CB2-AB5B-9A68A75EA793Q38266172-A3E18C2F-D205-4AD1-BB88-C0013B84C53AQ38602926-F8346B36-5098-473D-8F58-D6B514989EA5Q38851926-F2DC7F91-F110-4A3F-A5D6-6814C26F0BDEQ40431648-7B43E6C0-9477-4DEB-B7E4-0175E4554992Q40458879-657E2BBE-7651-4129-91A9-7A0B7ADD49E5Q40460067-9AF41F43-0F33-4A50-B4D4-41A299139323Q40516084-7FBD665C-9B1A-4FCF-8203-E93F981AB5C0Q40626046-7C1F064D-7FE8-4C42-826D-FC936A295580Q40716802-29E4C8E8-5CA4-4FAF-9B47-1C1025206F23Q40948116-F74E644D-2E23-4530-85AB-4757EF1E9344Q42723877-49C894CC-C6DC-4262-A2C3-BB93527B4F65Q44068261-4AF1847C-F932-4A4D-980D-102BBB0BA68FQ44367230-01A523C3-8752-48F2-B260-0845B0AB1B9CQ45023481-368696F8-70CD-4418-B6F4-E91EC4951847Q45246954-17E556C8-F583-44F6-9047-A13D37A23EA6Q45275828-FFBE754C-9833-44E7-862E-40BFAD7F108EQ46586540-D9825807-A14F-4159-B33B-95D7E23AE7A5Q51579173-5F9A5EE5-5696-4BAB-9A48-765B05C5F995Q79807888-44C46FE5-5F97-4E3A-B71D-38FB254F4AAD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Johan W. Jonker
@ast
Johan W. Jonker
@en
Johan W. Jonker
@es
Johan W. Jonker
@sl
type
label
Johan W. Jonker
@ast
Johan W. Jonker
@en
Johan W. Jonker
@es
Johan W. Jonker
@sl
prefLabel
Johan W. Jonker
@ast
Johan W. Jonker
@en
Johan W. Jonker
@es
Johan W. Jonker
@sl
P1006
P214
P1006
P106
P1153
7006630479
P21
P213
0000 0003 9706 8820
P214
P31
P496
0000-0002-3919-5437
P734
P735
P7859
viaf-292094793